FDA Import Refusal AEK-0976985-1/10002/1B — Eli Lilly Japan K.K.Seishin Laboratories
The FDA refused shipment AEK-0976985-1/10002/1B from Eli Lilly Japan K.K.Seishin Laboratories (Japan) on Sep 3, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charges: 118,3260,3280,75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Sep 3, 2026
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 61PCK74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 118,3260,3280,75